

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 4.13541768 |
| 2 | regulation of metalloenzyme activity (GO:0048552) | 4.05035196 |
| 3 | positive regulation of defense response to virus by host (GO:0002230) | 3.61759891 |
| 4 | nuclear envelope reassembly (GO:0031468) | 3.58030854 |
| 5 | mitotic nuclear envelope reassembly (GO:0007084) | 3.58030854 |
| 6 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.58024237 |
| 7 | DNA deamination (GO:0045006) | 3.54899639 |
| 8 | lipopolysaccharide biosynthetic process (GO:0009103) | 3.54423659 |
| 9 | response to gravity (GO:0009629) | 3.53626196 |
| 10 | activation of MAPKKK activity (GO:0000185) | 3.46997285 |
| 11 | leukocyte aggregation (GO:0070486) | 3.22201935 |
| 12 | negative regulation of interleukin-17 production (GO:0032700) | 3.19514549 |
| 13 | lipopolysaccharide metabolic process (GO:0008653) | 3.19032107 |
| 14 | response to peptidoglycan (GO:0032494) | 3.18501797 |
| 15 | mesodermal cell differentiation (GO:0048333) | 3.11034542 |
| 16 | negative regulation of mast cell activation (GO:0033004) | 3.09320085 |
| 17 | muscle cell migration (GO:0014812) | 3.06718416 |
| 18 | cellular response to zinc ion (GO:0071294) | 3.06714529 |
| 19 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.06238199 |
| 20 | purine nucleotide salvage (GO:0032261) | 3.04427838 |
| 21 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.03352705 |
| 22 | C-terminal protein lipidation (GO:0006501) | 2.97824690 |
| 23 | cellular response to arsenic-containing substance (GO:0071243) | 2.97312619 |
| 24 | protein maturation by protein folding (GO:0022417) | 2.90954657 |
| 25 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.90003348 |
| 26 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.90003348 |
| 27 | induction of positive chemotaxis (GO:0050930) | 2.87397039 |
| 28 | positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517) | 2.84213754 |
| 29 | platelet dense granule organization (GO:0060155) | 2.83935771 |
| 30 | morphogenesis of an endothelium (GO:0003159) | 2.82488422 |
| 31 | endothelial tube morphogenesis (GO:0061154) | 2.82488422 |
| 32 | I-kappaB kinase/NF-kappaB signaling (GO:0007249) | 2.79478334 |
| 33 | fibrinolysis (GO:0042730) | 2.79475695 |
| 34 | membrane raft organization (GO:0031579) | 2.79029915 |
| 35 | regulation of vitamin metabolic process (GO:0030656) | 2.76724118 |
| 36 | positive regulation of mitochondrial fission (GO:0090141) | 2.76593474 |
| 37 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.75139889 |
| 38 | regulation of interleukin-8 secretion (GO:2000482) | 2.73372670 |
| 39 | regulation of defense response to virus by host (GO:0050691) | 2.73135362 |
| 40 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.72142244 |
| 41 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.70748183 |
| 42 | positive regulation of actin filament depolymerization (GO:0030836) | 2.70130413 |
| 43 | regulation of chemokine biosynthetic process (GO:0045073) | 2.69084664 |
| 44 | eosinophil chemotaxis (GO:0048245) | 2.69072628 |
| 45 | nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423) | 2.68944498 |
| 46 | mannosylation (GO:0097502) | 2.68164273 |
| 47 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.67690005 |
| 48 | rRNA transcription (GO:0009303) | 2.64587416 |
| 49 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.63696879 |
| 50 | galactose metabolic process (GO:0006012) | 2.62300348 |
| 51 | response to interferon-beta (GO:0035456) | 2.60810384 |
| 52 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.59549628 |
| 53 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.59127589 |
| 54 | establishment of viral latency (GO:0019043) | 2.58078728 |
| 55 | C-terminal protein amino acid modification (GO:0018410) | 2.54215933 |
| 56 | sphingosine metabolic process (GO:0006670) | 2.53789560 |
| 57 | negative regulation of interleukin-1 production (GO:0032692) | 2.53438705 |
| 58 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.51433028 |
| 59 | cullin deneddylation (GO:0010388) | 2.48744391 |
| 60 | positive regulation of signal transduction by p53 class mediator (GO:1901798) | 2.47902372 |
| 61 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 2.47722586 |
| 62 | intracellular pH reduction (GO:0051452) | 2.47150302 |
| 63 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.47128128 |
| 64 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.46989621 |
| 65 | proteasome assembly (GO:0043248) | 2.44243991 |
| 66 | negative regulation of mitochondrion organization (GO:0010823) | 2.42327209 |
| 67 | regulation of positive chemotaxis (GO:0050926) | 2.40751120 |
| 68 | positive regulation of positive chemotaxis (GO:0050927) | 2.39499113 |
| 69 | regulation of interleukin-17 production (GO:0032660) | 2.38792484 |
| 70 | NIK/NF-kappaB signaling (GO:0038061) | 2.38626691 |
| 71 | cell adhesion mediated by integrin (GO:0033627) | 2.38537281 |
| 72 | eosinophil migration (GO:0072677) | 2.38420571 |
| 73 | regulation of thymocyte apoptotic process (GO:0070243) | 2.38368902 |
| 74 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.37165650 |
| 75 | response to hyperoxia (GO:0055093) | 2.35093274 |
| 76 | response to increased oxygen levels (GO:0036296) | 2.35093274 |
| 77 | maintenance of protein location in nucleus (GO:0051457) | 2.35047263 |
| 78 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.34588906 |
| 79 | response to protozoan (GO:0001562) | 2.34505174 |
| 80 | lung vasculature development (GO:0060426) | 2.32962293 |
| 81 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.32251938 |
| 82 | myelin assembly (GO:0032288) | 2.31448455 |
| 83 | positive regulation of TOR signaling (GO:0032008) | 2.31214350 |
| 84 | negative regulation of JAK-STAT cascade (GO:0046426) | 2.31205708 |
| 85 | negative regulation of interleukin-12 production (GO:0032695) | 2.31069611 |
| 86 | tRNA methylation (GO:0030488) | 2.30921148 |
| 87 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 2.30882096 |
| 88 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 2.30882096 |
| 89 | regulation of mitochondrial fission (GO:0090140) | 2.30655422 |
| 90 | nucleotide salvage (GO:0043173) | 2.30055244 |
| 91 | positive regulation of protein homooligomerization (GO:0032464) | 2.29465257 |
| 92 | protein deneddylation (GO:0000338) | 2.29228878 |
| 93 | virion attachment to host cell (GO:0019062) | 2.28889100 |
| 94 | adhesion of symbiont to host cell (GO:0044650) | 2.28889100 |
| 95 | positive regulation of pseudopodium assembly (GO:0031274) | 2.28213538 |
| 96 | substrate-dependent cell migration (GO:0006929) | 2.27951035 |
| 97 | defense response to protozoan (GO:0042832) | 2.27865755 |
| 98 | amino sugar catabolic process (GO:0046348) | 2.27098639 |
| 99 | endosome to pigment granule transport (GO:0043485) | 2.26992796 |
| 100 | endosome to melanosome transport (GO:0035646) | 2.26992796 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.89230670 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.72142429 |
| 3 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.70973631 |
| 4 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.57887132 |
| 5 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 3.25019977 |
| 6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.79587903 |
| 7 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.74770103 |
| 8 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.59054528 |
| 9 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.55177433 |
| 10 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.49807159 |
| 11 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.27386334 |
| 12 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.12953243 |
| 13 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.11485652 |
| 14 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.10633245 |
| 15 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.04744373 |
| 16 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.03681612 |
| 17 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 2.01557102 |
| 18 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.97821647 |
| 19 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.97821647 |
| 20 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.94170638 |
| 21 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.87027272 |
| 22 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.86159375 |
| 23 | CJUN_26792858_Chip-Seq_BT549_Human | 1.84370550 |
| 24 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.82034979 |
| 25 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.78977326 |
| 26 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.78591066 |
| 27 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.75407939 |
| 28 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75083073 |
| 29 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.74601539 |
| 30 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.72003227 |
| 31 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71412867 |
| 32 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.69848779 |
| 33 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.69697088 |
| 34 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.67084606 |
| 35 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.65926049 |
| 36 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.65157022 |
| 37 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.61714982 |
| 38 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.61124038 |
| 39 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.60841625 |
| 40 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.59383922 |
| 41 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.57073167 |
| 42 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.55420997 |
| 43 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.54621757 |
| 44 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.51970162 |
| 45 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.50332482 |
| 46 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.48954211 |
| 47 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45705657 |
| 48 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.45161790 |
| 49 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.44237479 |
| 50 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.41740968 |
| 51 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.41183237 |
| 52 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.39532368 |
| 53 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.37551084 |
| 54 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.36606417 |
| 55 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31361093 |
| 56 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.30735876 |
| 57 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.29989807 |
| 58 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.29725052 |
| 59 | ATF3_27146783_Chip-Seq_COLON_Human | 1.26027837 |
| 60 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.25436252 |
| 61 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.24847295 |
| 62 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.23718447 |
| 63 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23238887 |
| 64 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.22770396 |
| 65 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.21941535 |
| 66 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.21878941 |
| 67 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.20468042 |
| 68 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.19516258 |
| 69 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.19032585 |
| 70 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.18350950 |
| 71 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.16854419 |
| 72 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.13163422 |
| 73 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.10614974 |
| 74 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.10170587 |
| 75 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08409556 |
| 76 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.05810250 |
| 77 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.05578907 |
| 78 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.04404607 |
| 79 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.04050284 |
| 80 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.03769181 |
| 81 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.03561595 |
| 82 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.02613075 |
| 83 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.02606746 |
| 84 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.02004292 |
| 85 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.00987335 |
| 86 | P300_27268052_Chip-Seq_Bcells_Human | 1.00259213 |
| 87 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98346058 |
| 88 | TP53_16413492_ChIP-PET_HCT116_Human | 0.97532254 |
| 89 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.95379086 |
| 90 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.95315035 |
| 91 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.95000250 |
| 92 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.94070086 |
| 93 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.92914298 |
| 94 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.92676582 |
| 95 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.90528669 |
| 96 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.89880764 |
| 97 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89746036 |
| 98 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.89635548 |
| 99 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.89299236 |
| 100 | SPI1_23127762_ChIP-Seq_K562_Human | 0.87974224 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005623_abnormal_meninges_morphology | 3.56169560 |
| 2 | MP0000750_abnormal_muscle_regeneration | 3.42978064 |
| 3 | MP0006054_spinal_hemorrhage | 3.10462285 |
| 4 | MP0003436_decreased_susceptibility_to | 2.97253016 |
| 5 | MP0003191_abnormal_cellular_cholesterol | 2.87369914 |
| 6 | MP0009764_decreased_sensitivity_to | 2.75430818 |
| 7 | MP0009840_abnormal_foam_cell | 2.66364061 |
| 8 | MP0000013_abnormal_adipose_tissue | 2.58627155 |
| 9 | MP0002254_reproductive_system_inflammat | 2.53770186 |
| 10 | MP0003950_abnormal_plasma_membrane | 2.53158253 |
| 11 | MP0002332_abnormal_exercise_endurance | 2.53027620 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 2.41812430 |
| 13 | MP0004510_myositis | 2.23906484 |
| 14 | MP0000858_altered_metastatic_potential | 2.16101143 |
| 15 | MP0000343_altered_response_to | 2.00684601 |
| 16 | MP0003786_premature_aging | 1.98546011 |
| 17 | MP0005164_abnormal_response_to | 1.97788552 |
| 18 | MP0003724_increased_susceptibility_to | 1.96832328 |
| 19 | MP0005410_abnormal_fertilization | 1.94643060 |
| 20 | MP0001542_abnormal_bone_strength | 1.90406021 |
| 21 | MP0004947_skin_inflammation | 1.82491852 |
| 22 | MP0003656_abnormal_erythrocyte_physiolo | 1.82057003 |
| 23 | MP0009785_altered_susceptibility_to | 1.81908356 |
| 24 | MP0001853_heart_inflammation | 1.79474750 |
| 25 | MP0002419_abnormal_innate_immunity | 1.79441850 |
| 26 | MP0006082_CNS_inflammation | 1.74384370 |
| 27 | MP0003195_calcinosis | 1.72752782 |
| 28 | MP0003279_aneurysm | 1.72674842 |
| 29 | MP0003075_altered_response_to | 1.71242739 |
| 30 | MP0005257_abnormal_intraocular_pressure | 1.70279177 |
| 31 | MP0001533_abnormal_skeleton_physiology | 1.63517393 |
| 32 | MP0005058_abnormal_lysosome_morphology | 1.54606421 |
| 33 | MP0002877_abnormal_melanocyte_morpholog | 1.52188789 |
| 34 | MP0005000_abnormal_immune_tolerance | 1.50570324 |
| 35 | MP0001835_abnormal_antigen_presentation | 1.46311264 |
| 36 | MP0002452_abnormal_antigen_presenting | 1.45768609 |
| 37 | MP0005165_increased_susceptibility_to | 1.42461943 |
| 38 | MP0005166_decreased_susceptibility_to | 1.39599436 |
| 39 | MP0008438_abnormal_cutaneous_collagen | 1.39580097 |
| 40 | MP0003806_abnormal_nucleotide_metabolis | 1.38426468 |
| 41 | MP0003186_abnormal_redox_activity | 1.37420687 |
| 42 | MP0008004_abnormal_stomach_pH | 1.36588337 |
| 43 | MP0002723_abnormal_immune_serum | 1.32083580 |
| 44 | MP0008469_abnormal_protein_level | 1.31022763 |
| 45 | MP0000749_muscle_degeneration | 1.28013165 |
| 46 | MP0005464_abnormal_platelet_physiology | 1.24378214 |
| 47 | MP0005360_urolithiasis | 1.23247261 |
| 48 | MP0005025_abnormal_response_to | 1.21331400 |
| 49 | MP0008260_abnormal_autophagy | 1.14742358 |
| 50 | MP0000372_irregular_coat_pigmentation | 1.14631154 |
| 51 | MP0001545_abnormal_hematopoietic_system | 1.09607814 |
| 52 | MP0005397_hematopoietic_system_phenotyp | 1.09607814 |
| 53 | MP0005390_skeleton_phenotype | 1.08498901 |
| 54 | MP0001243_abnormal_dermal_layer | 1.07846169 |
| 55 | MP0002282_abnormal_trachea_morphology | 1.06641177 |
| 56 | MP0001845_abnormal_inflammatory_respons | 1.06402425 |
| 57 | MP0009333_abnormal_splenocyte_physiolog | 1.06234354 |
| 58 | MP0003448_altered_tumor_morphology | 1.05839754 |
| 59 | MP0009765_abnormal_xenobiotic_induced | 1.05506162 |
| 60 | MP0003566_abnormal_cell_adhesion | 1.04730250 |
| 61 | MP0002405_respiratory_system_inflammati | 1.03677175 |
| 62 | MP0005367_renal/urinary_system_phenotyp | 1.03652740 |
| 63 | MP0000516_abnormal_urinary_system | 1.03652740 |
| 64 | MP0005451_abnormal_body_composition | 1.03534280 |
| 65 | MP0000604_amyloidosis | 1.02848911 |
| 66 | MP0009384_cardiac_valve_regurgitation | 1.02682400 |
| 67 | MP0000762_abnormal_tongue_morphology | 1.02326138 |
| 68 | MP0004272_abnormal_basement_membrane | 1.01665446 |
| 69 | MP0002132_abnormal_respiratory_system | 1.01265685 |
| 70 | MP0010368_abnormal_lymphatic_system | 1.00176680 |
| 71 | MP0001819_abnormal_immune_cell | 0.99530516 |
| 72 | MP0002420_abnormal_adaptive_immunity | 0.98814067 |
| 73 | MP0002060_abnormal_skin_morphology | 0.95518506 |
| 74 | MP0002177_abnormal_outer_ear | 0.95490374 |
| 75 | MP0001800_abnormal_humoral_immune | 0.95102443 |
| 76 | MP0008007_abnormal_cellular_replicative | 0.94227411 |
| 77 | MP0009697_abnormal_copulation | 0.93157346 |
| 78 | MP0008775_abnormal_heart_ventricle | 0.93003771 |
| 79 | MP0009278_abnormal_bone_marrow | 0.92013425 |
| 80 | MP0001790_abnormal_immune_system | 0.91261050 |
| 81 | MP0005387_immune_system_phenotype | 0.91261050 |
| 82 | MP0000358_abnormal_cell_content/ | 0.86886675 |
| 83 | MP0005023_abnormal_wound_healing | 0.85128385 |
| 84 | MP0009763_increased_sensitivity_to | 0.84823932 |
| 85 | MP0005197_abnormal_uvea_morphology | 0.84213621 |
| 86 | MP0000647_abnormal_sebaceous_gland | 0.83417339 |
| 87 | MP0000249_abnormal_blood_vessel | 0.81579880 |
| 88 | MP0002933_joint_inflammation | 0.81224709 |
| 89 | MP0000427_abnormal_hair_cycle | 0.79154236 |
| 90 | MP0002168_other_aberrant_phenotype | 0.78723295 |
| 91 | MP0003828_pulmonary_edema | 0.78467926 |
| 92 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.74530777 |
| 93 | MP0005376_homeostasis/metabolism_phenot | 0.73687369 |
| 94 | MP0004147_increased_porphyrin_level | 0.73430488 |
| 95 | MP0008873_increased_physiological_sensi | 0.73087355 |
| 96 | MP0000685_abnormal_immune_system | 0.72939439 |
| 97 | MP0005167_abnormal_blood-brain_barrier | 0.71894829 |
| 98 | MP0001216_abnormal_epidermal_layer | 0.70386292 |
| 99 | MP0002277_abnormal_respiratory_mucosa | 0.70102496 |
| 100 | MP0000751_myopathy | 0.69950982 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Type II lissencephaly (HP:0007260) | 6.40882967 |
| 2 | Cerebellar dysplasia (HP:0007033) | 6.12986933 |
| 3 | Fatigue (HP:0012378) | 5.39650124 |
| 4 | Retinal atrophy (HP:0001105) | 5.38025883 |
| 5 | Retinal dysplasia (HP:0007973) | 5.34731531 |
| 6 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 5.06043080 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.70950230 |
| 8 | Hypoplasia of the pons (HP:0012110) | 4.65626882 |
| 9 | Difficulty climbing stairs (HP:0003551) | 4.48278537 |
| 10 | Abnormality of the pons (HP:0007361) | 4.18582297 |
| 11 | Abnormality of glycolipid metabolism (HP:0010969) | 3.81757131 |
| 12 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.81757131 |
| 13 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.81757131 |
| 14 | Entropion (HP:0000621) | 3.70617615 |
| 15 | Severe muscular hypotonia (HP:0006829) | 3.63498231 |
| 16 | Amyloidosis (HP:0011034) | 3.39155897 |
| 17 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.21550559 |
| 18 | Abnormality of alanine metabolism (HP:0010916) | 3.21550559 |
| 19 | Hyperalaninemia (HP:0003348) | 3.21550559 |
| 20 | Vacuolated lymphocytes (HP:0001922) | 3.00554817 |
| 21 | Abolished electroretinogram (ERG) (HP:0000550) | 2.93112558 |
| 22 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.76649489 |
| 23 | Buphthalmos (HP:0000557) | 2.74370567 |
| 24 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.66844969 |
| 25 | Premature rupture of membranes (HP:0001788) | 2.63521234 |
| 26 | Stomatitis (HP:0010280) | 2.58647225 |
| 27 | Abnormal protein glycosylation (HP:0012346) | 2.53422761 |
| 28 | Abnormal glycosylation (HP:0012345) | 2.53422761 |
| 29 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.53422761 |
| 30 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.53422761 |
| 31 | Glucose intolerance (HP:0000833) | 2.53290302 |
| 32 | Follicular hyperkeratosis (HP:0007502) | 2.46922712 |
| 33 | Decreased subcutaneous fat (HP:0001002) | 2.42541513 |
| 34 | Myocardial infarction (HP:0001658) | 2.41193079 |
| 35 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.40209717 |
| 36 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.40209717 |
| 37 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.40209717 |
| 38 | Concave nail (HP:0001598) | 2.23549354 |
| 39 | Type I transferrin isoform profile (HP:0003642) | 2.22738782 |
| 40 | Brittle hair (HP:0002299) | 2.20713851 |
| 41 | Congenital glaucoma (HP:0001087) | 2.20387050 |
| 42 | Increased IgM level (HP:0003496) | 2.16958506 |
| 43 | Thick nail (HP:0001805) | 2.13148149 |
| 44 | IgG deficiency (HP:0004315) | 2.12859132 |
| 45 | Prolonged neonatal jaundice (HP:0006579) | 2.11774956 |
| 46 | Delayed CNS myelination (HP:0002188) | 2.09436209 |
| 47 | Adactyly (HP:0009776) | 2.08215625 |
| 48 | Lissencephaly (HP:0001339) | 2.08090990 |
| 49 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.05360038 |
| 50 | Atrophic scars (HP:0001075) | 2.03121149 |
| 51 | Muscular dystrophy (HP:0003560) | 1.99198636 |
| 52 | Reduced antithrombin III activity (HP:0001976) | 1.98318415 |
| 53 | Upper limb muscle weakness (HP:0003484) | 1.98203506 |
| 54 | Dysostosis multiplex (HP:0000943) | 1.96788595 |
| 55 | Fragile nails (HP:0001808) | 1.95494584 |
| 56 | Delayed gross motor development (HP:0002194) | 1.92758671 |
| 57 | Keratitis (HP:0000491) | 1.90975889 |
| 58 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.90432241 |
| 59 | Mucopolysacchariduria (HP:0008155) | 1.90432241 |
| 60 | Abnormality of macrophages (HP:0004311) | 1.88978023 |
| 61 | Sparse eyelashes (HP:0000653) | 1.88729806 |
| 62 | Axonal loss (HP:0003447) | 1.87690434 |
| 63 | Neonatal respiratory distress (HP:0002643) | 1.82241636 |
| 64 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.79986320 |
| 65 | Absent speech (HP:0001344) | 1.78185564 |
| 66 | Short nail (HP:0001799) | 1.78106844 |
| 67 | Peritonitis (HP:0002586) | 1.78072468 |
| 68 | Increased cerebral lipofuscin (HP:0011813) | 1.77661599 |
| 69 | Poikiloderma (HP:0001029) | 1.77479514 |
| 70 | Increased serum pyruvate (HP:0003542) | 1.76390579 |
| 71 | Impaired platelet aggregation (HP:0003540) | 1.75287853 |
| 72 | Abnormal platelet function (HP:0011869) | 1.75287853 |
| 73 | Flat capital femoral epiphysis (HP:0003370) | 1.75216207 |
| 74 | Abnormal spermatogenesis (HP:0008669) | 1.75019769 |
| 75 | Hepatocellular necrosis (HP:0001404) | 1.74903561 |
| 76 | Myositis (HP:0100614) | 1.73936284 |
| 77 | Erythroderma (HP:0001019) | 1.73916421 |
| 78 | Adrenal hypoplasia (HP:0000835) | 1.71432643 |
| 79 | Meningocele (HP:0002435) | 1.70978960 |
| 80 | Bradycardia (HP:0001662) | 1.70544529 |
| 81 | Cone-rod dystrophy (HP:0000548) | 1.68445649 |
| 82 | Onycholysis (HP:0001806) | 1.67357198 |
| 83 | Rough bone trabeculation (HP:0100670) | 1.67264117 |
| 84 | Orchitis (HP:0100796) | 1.66872979 |
| 85 | Conical tooth (HP:0000698) | 1.64843106 |
| 86 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.64733370 |
| 87 | Anorexia (HP:0002039) | 1.61250635 |
| 88 | Constricted visual fields (HP:0001133) | 1.60195076 |
| 89 | Alopecia of scalp (HP:0002293) | 1.59986586 |
| 90 | Increased serum ferritin (HP:0003281) | 1.59023856 |
| 91 | Joint stiffness (HP:0001387) | 1.57198823 |
| 92 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.56143524 |
| 93 | Submucous cleft hard palate (HP:0000176) | 1.56105213 |
| 94 | Gowers sign (HP:0003391) | 1.54841318 |
| 95 | Choroideremia (HP:0001139) | 1.53604236 |
| 96 | Nail dystrophy (HP:0008404) | 1.51750767 |
| 97 | IgA deficiency (HP:0002720) | 1.51109993 |
| 98 | Joint hemorrhage (HP:0005261) | 1.50861445 |
| 99 | Severe visual impairment (HP:0001141) | 1.50110971 |
| 100 | Large eyes (HP:0001090) | 1.49148563 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 4.14365718 |
| 2 | STK10 | 3.62569712 |
| 3 | EPHA2 | 3.21402416 |
| 4 | TESK2 | 3.15305462 |
| 5 | TESK1 | 3.13178835 |
| 6 | NME2 | 3.02245353 |
| 7 | LIMK1 | 2.68068325 |
| 8 | PIM2 | 2.64439984 |
| 9 | MARK3 | 2.59451820 |
| 10 | PDK2 | 2.33656702 |
| 11 | MAP3K3 | 2.30556003 |
| 12 | VRK2 | 2.23670698 |
| 13 | MAP3K11 | 1.97199282 |
| 14 | TRIM28 | 1.83691461 |
| 15 | GRK7 | 1.71957316 |
| 16 | TLK1 | 1.71604062 |
| 17 | MAP3K14 | 1.71558816 |
| 18 | ERN1 | 1.70731082 |
| 19 | PTK2B | 1.68440375 |
| 20 | IKBKB | 1.68005337 |
| 21 | TGFBR2 | 1.64507920 |
| 22 | SIK3 | 1.62349320 |
| 23 | LMTK2 | 1.57970860 |
| 24 | TAOK2 | 1.56344025 |
| 25 | ZAK | 1.56017832 |
| 26 | MST1R | 1.45470352 |
| 27 | MAP3K12 | 1.40168168 |
| 28 | MAP2K3 | 1.39456987 |
| 29 | ABL2 | 1.36223168 |
| 30 | ERBB4 | 1.33070067 |
| 31 | ADRBK2 | 1.20389338 |
| 32 | MOS | 1.18666666 |
| 33 | TBK1 | 1.17889318 |
| 34 | TAOK3 | 1.16219221 |
| 35 | BCKDK | 1.13346910 |
| 36 | IRAK1 | 1.10095354 |
| 37 | TXK | 1.05564059 |
| 38 | MAP2K7 | 1.03311937 |
| 39 | ARAF | 1.01853936 |
| 40 | FLT3 | 1.00267272 |
| 41 | PIM1 | 0.98494858 |
| 42 | MYLK | 0.97071687 |
| 43 | FRK | 0.94634166 |
| 44 | PAK4 | 0.92106100 |
| 45 | ADRBK1 | 0.91394224 |
| 46 | IKBKE | 0.90358060 |
| 47 | PRKCI | 0.87178513 |
| 48 | MST4 | 0.85430485 |
| 49 | BRSK2 | 0.84485514 |
| 50 | EPHB1 | 0.83540078 |
| 51 | NUAK1 | 0.83122409 |
| 52 | VRK1 | 0.80709385 |
| 53 | CHUK | 0.80705730 |
| 54 | CSNK1G3 | 0.80049787 |
| 55 | CSNK1A1L | 0.74714210 |
| 56 | MUSK | 0.72351607 |
| 57 | GSK3A | 0.67187903 |
| 58 | CCNB1 | 0.66012288 |
| 59 | EPHA3 | 0.61565541 |
| 60 | GRK1 | 0.60431710 |
| 61 | CDK8 | 0.58883462 |
| 62 | RPS6KA5 | 0.58097959 |
| 63 | EPHB2 | 0.55928952 |
| 64 | CSNK1G1 | 0.51080758 |
| 65 | JAK3 | 0.50699529 |
| 66 | IRAK2 | 0.48045073 |
| 67 | BUB1 | 0.47987930 |
| 68 | PRKD2 | 0.46624965 |
| 69 | DAPK1 | 0.46611664 |
| 70 | GRK5 | 0.46551704 |
| 71 | ZAP70 | 0.44645488 |
| 72 | PRKCE | 0.43920017 |
| 73 | RPS6KA4 | 0.43811573 |
| 74 | CSNK1G2 | 0.42499470 |
| 75 | MET | 0.40797209 |
| 76 | AURKA | 0.39606455 |
| 77 | PRKG2 | 0.39445413 |
| 78 | TYK2 | 0.39031308 |
| 79 | STK16 | 0.38395123 |
| 80 | FER | 0.38024928 |
| 81 | PTK2 | 0.37526072 |
| 82 | MAP3K5 | 0.37487744 |
| 83 | IRAK4 | 0.37407943 |
| 84 | CAMKK2 | 0.37054747 |
| 85 | ERBB3 | 0.36907104 |
| 86 | MAP4K2 | 0.35252522 |
| 87 | KIT | 0.33891639 |
| 88 | BMPR1B | 0.32476618 |
| 89 | ABL1 | 0.31369660 |
| 90 | PIK3CG | 0.31157748 |
| 91 | MAP4K1 | 0.29738266 |
| 92 | ROCK1 | 0.29553355 |
| 93 | KDR | 0.29022113 |
| 94 | EIF2AK2 | 0.28273584 |
| 95 | MAPK11 | 0.26373691 |
| 96 | SRPK1 | 0.25980409 |
| 97 | DDR2 | 0.25018481 |
| 98 | BLK | 0.25018132 |
| 99 | DAPK3 | 0.24493910 |
| 100 | PRKD1 | 0.24475133 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.90998009 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 2.76267508 |
| 3 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.68532202 |
| 4 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.60617212 |
| 5 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.56048513 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.45069897 |
| 7 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.31687340 |
| 8 | Other glycan degradation_Homo sapiens_hsa00511 | 2.29252628 |
| 9 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.20345595 |
| 10 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.18116987 |
| 11 | Legionellosis_Homo sapiens_hsa05134 | 2.10332639 |
| 12 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 2.08304376 |
| 13 | Sulfur relay system_Homo sapiens_hsa04122 | 2.02530412 |
| 14 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.97914268 |
| 15 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.97492017 |
| 16 | Lysosome_Homo sapiens_hsa04142 | 1.83921877 |
| 17 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.79818701 |
| 18 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.78371550 |
| 19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.50927055 |
| 20 | Leishmaniasis_Homo sapiens_hsa05140 | 1.49238492 |
| 21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.47975572 |
| 22 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.43906643 |
| 23 | Salmonella infection_Homo sapiens_hsa05132 | 1.42287716 |
| 24 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.41856905 |
| 25 | Shigellosis_Homo sapiens_hsa05131 | 1.40283171 |
| 26 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.38501941 |
| 27 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.36362911 |
| 28 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.34744341 |
| 29 | Allograft rejection_Homo sapiens_hsa05330 | 1.34232346 |
| 30 | RNA polymerase_Homo sapiens_hsa03020 | 1.29611632 |
| 31 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.28101233 |
| 32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.27478230 |
| 33 | Pertussis_Homo sapiens_hsa05133 | 1.23568078 |
| 34 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.23103025 |
| 35 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.22987080 |
| 36 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.19047964 |
| 37 | Tuberculosis_Homo sapiens_hsa05152 | 1.18281619 |
| 38 | Homologous recombination_Homo sapiens_hsa03440 | 1.16775981 |
| 39 | Galactose metabolism_Homo sapiens_hsa00052 | 1.14672713 |
| 40 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.13322985 |
| 41 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.10105069 |
| 42 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.07764413 |
| 43 | Basal transcription factors_Homo sapiens_hsa03022 | 1.07548617 |
| 44 | Phagosome_Homo sapiens_hsa04145 | 1.07529335 |
| 45 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.06690156 |
| 46 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.06466135 |
| 47 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.05258238 |
| 48 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.04161749 |
| 49 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.02583514 |
| 50 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.00347844 |
| 51 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.99644932 |
| 52 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.97558259 |
| 53 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.97190080 |
| 54 | Malaria_Homo sapiens_hsa05144 | 0.95981001 |
| 55 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.94426354 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.93760496 |
| 57 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.91973465 |
| 58 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.91587922 |
| 59 | Influenza A_Homo sapiens_hsa05164 | 0.91407272 |
| 60 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.90735954 |
| 61 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.86422290 |
| 62 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.84386175 |
| 63 | Base excision repair_Homo sapiens_hsa03410 | 0.83704809 |
| 64 | Asthma_Homo sapiens_hsa05310 | 0.83690263 |
| 65 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.81253635 |
| 66 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.81240329 |
| 67 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.80085978 |
| 68 | Apoptosis_Homo sapiens_hsa04210 | 0.79679701 |
| 69 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.70308402 |
| 70 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.70177692 |
| 71 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.69498807 |
| 72 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.69067415 |
| 73 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.68467296 |
| 74 | Mineral absorption_Homo sapiens_hsa04978 | 0.68376818 |
| 75 | Alcoholism_Homo sapiens_hsa05034 | 0.68115113 |
| 76 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.67811649 |
| 77 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.65978047 |
| 78 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.65147223 |
| 79 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.64642981 |
| 80 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.63751058 |
| 81 | Measles_Homo sapiens_hsa05162 | 0.63638111 |
| 82 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.62947562 |
| 83 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.61845808 |
| 84 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.60586093 |
| 85 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.59625041 |
| 86 | Bladder cancer_Homo sapiens_hsa05219 | 0.57660758 |
| 87 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.55548795 |
| 88 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.55020247 |
| 89 | Protein export_Homo sapiens_hsa03060 | 0.54444670 |
| 90 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.53843594 |
| 91 | Huntingtons disease_Homo sapiens_hsa05016 | 0.53447377 |
| 92 | Viral myocarditis_Homo sapiens_hsa05416 | 0.52255322 |
| 93 | Phototransduction_Homo sapiens_hsa04744 | 0.49999017 |
| 94 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.48963096 |
| 95 | Circadian rhythm_Homo sapiens_hsa04710 | 0.48711039 |
| 96 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.47741924 |
| 97 | Hepatitis B_Homo sapiens_hsa05161 | 0.46744808 |
| 98 | Purine metabolism_Homo sapiens_hsa00230 | 0.45757656 |
| 99 | Salivary secretion_Homo sapiens_hsa04970 | 0.43737636 |
| 100 | Peroxisome_Homo sapiens_hsa04146 | 0.43661251 |

